A biomarker can be defined as a biological characteristic of an organism
that is measured as an indicator of normal biological process. Renal biomarkers
are an important tool in diagnosis of various kidney diseases and detection of
acute and chronic kidney injuries. An ideal renal biomarker must be able to
detect kidney disorders at the initial stage.
Global
Renal Biomarkers Market: Drivers
Increasing prevalence of chronic
kidney diseases is expected to propel growth of the global renal biomarkersmarket over the forecast period. For instance, according to European Renal
Association – European Dialysis and Transplant Association’s data in 2018, over
850 million people worldwide have some form of kidney disease.
Moreover, use of unreliable, imperfect gold standards is also expected
to limit growth of the market. Serum creatinine, although having low
sensitivity and specificity, is used as gold standard. Serum creatinine does
not distinguish whether the reason for rise in levels is due to renal injury or
other non-renal causes such as hemodynamic (obstructive uropathy) mediated
changes. Moreover, serum creatinine is also not effective in renal recovery and
injury.
Comments
Post a Comment